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Abstract
Background: Copy number variants (CNVs) account for a large proportion of genetic variation
in the genome. The initial discoveries of long (> 100 kb) CNVs in normal healthy individuals were
made on BAC arrays and low resolution oligonucleotide arrays. Subsequent studies that used
higher resolution microarrays and SNP genotyping arrays detected the presence of large numbers
of CNVs that are < 100 kb, with median lengths of approximately 10 kb. More recently, whole
genome sequencing of individuals has revealed an abundance of shorter CNVs with lengths < 1 kb.
Results:  We used custom high density oligonucleotide arrays in whole-genome scans at
approximately 200-bp resolution, and followed up with a localized CNV typing array at resolutions
as close as 10 bp, to confirm regions from the initial genome scans, and to detect the occurrence
of sample-level events at shorter CNV regions identified in recent whole-genome sequencing
studies. We surveyed 90 Yoruba Nigerians from the HapMap Project, and uncovered
approximately 2,700 potentially novel CNVs not previously reported in the literature having a
median length of approximately 3 kb. We generated sample-level event calls in the 90 Yoruba at
nearly 9,000 regions, including approximately 2,500 regions having a median length of just
approximately 200 bp that represent the union of CNVs independently discovered through whole-
genome sequencing of two individuals of Western European descent. Event frequencies were
noticeably higher at shorter regions < 1 kb compared to longer CNVs (> 1 kb).
Conclusions: As new shorter CNVs are discovered through whole-genome sequencing, high
resolution microarrays offer a cost-effective means to detect the occurrence of events at these
regions in large numbers of individuals in order to gain biological insights beyond the initial
discovery.
Background
Genetic differences between individuals occur at many levels,
starting with single nucleotide polymorphisms (SNPs) [1],
short insertions and deletions of several nucleotides (indels)
[2], and extending out to copy number variants (CNVs) that
span several orders of magnitude in length [3]. A thorough
cataloging of genetic variations in the human genome is well
underway, as evidenced by the HapMap Project [1] and 1,000
Genomes Project [4], and data repositories such as dbSNP [5]
and the Database of Genomic Variants (DGV) [6]. The ability
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to genotype large numbers of individuals in various study
cohorts at large numbers of known loci has in turn led to sig-
nificant associations between specific genetic differences and
phenotypic differences, which often manifest as complex dis-
orders. Recent notable studies have associated SNP markers
with bipolar disorder, coronary artery disease, Crohn's dis-
ease, hypertension, rheumatoid arthritis, type 1 diabetes, and
type 2 diabetes [7], and CNVs with autism and schizophrenia
[8-10].
Progressively higher resolution microarrays, starting with
earlier low resolution bacterial artificial chromosome (BAC)
arrays followed by commercially available array comparative
genome hybridization (CGH) and SNP genotyping arrays,
have steadily driven the discovery of new CNVs and have
refined the boundaries of earlier reported CNVs. Specifically,
the earliest CNVs described by Sebat et al. [11] and Iafrate et
al. [6], using BAC arrays and lower resolution oligonucleotide
arrays, had median lengths of approximately 222 kb and
approximately 156 kb, respectively. Later, Redon et al. [12]
used both BAC arrays and SNP genotyping arrays from
Affymetrix to report CNVs with median lengths of approxi-
mately 234 kb and approximately 63 kb, respectively. More
recent examples are the Perry et al. [13] study, which used
Agilent high resolution CGH arrays, the McCarroll et al. [14]
study, which used the Affymetrix SNP 6.0 array, and the
Wang et al. [15] study, which used data from Illumina Bead-
Chips. The Perry et al. [13] study examined known regions in
the DGV (November 2006) at approximately 1 kb resolution,
and refined the lengths of over 1,000 CNVs to a revised
median length of approximately 10.2 kb. The Wang et al. [15]
study analyzed genome-wide SNP genotype data having
median inter-SNP distance of approximately 3 kb from over a
hundred individuals to detect CNVs having median lengths of
approximately 12 kb. The McCarroll et al. [14] study exam-
ined the entire genome (as represented in the whole-genome
sampling of NspI and StyI restriction fragments) at approxi-
mately 2-kb resolution, and reported > 1,300 CNVs having a
median length of approximately 7.4 kb.
Here in this study, we set out to demonstrate the benefits, as
well as limitations, of Affymetrix oligonucleotide arrays with
higher resolution than previously available arrays, first in
unbiased whole-genome scans to discover CNV regions, and
subsequently in localized regions to determine sample-level
CNV calls. Our custom arrays were manufactured using
standard Affymetrix processes [16], but with phosphora-
midite nucleosides bearing an improved protecting group to
provide for more efficient photolysis and chain extension
[17], which enabled the synthesis of longer probes. We first
used our genome-scan arrays to examine the entire genome
with uniform coverage at a resolution of approximately 200
bp. We designed a set of three custom oligonucleotide whole-
genome scan arrays that span the entire non-repetitive por-
tion of the human genome. Each of the genome-scan arrays
consists of over 10 million 49-nucleotide long probes that are
spaced at a median distance of approximately 200 bp apart
along the chromosomes. The set of 90 Yoruba Nigerians from
the HapMap Project [1] was chosen for the scans because they
represent an anthropologically early population likely to be
harboring a fair proportion of common and more older CNVs,
similar to the occurrence of common SNPs [1]. A number of
previous CNV studies also used some or all of the Yoruba indi-
viduals, making it possible to compare event calls reported in
the literature with those observed in our work. Additionally,
because the 90 Yoruba individuals are each members of 30
family trios, inheritance patterns of the observed and
reported events can be measures of accuracy and event call
completeness.
A fourth custom oligonucleotide array was designed to con-
firm putative CNV regions identified from the initial genome
scans, as well as subsets of CNVs reported in the DGV
(November 2008), including those reported by Perry et al.
[13], Wang et al. [15], and McCarroll et al. [14], and to deter-
mine sample-level event occurrence. Additionally, we were
particularly interested in observing events in the 90 Yoruba at
shorter CNVs discovered through the whole-genome
sequencing of two individuals. The design of our CNV-typing
array prioritized CNVs reported in the landmark Levy et al.
[18] and Wheeler et al. [19] studies, which contributed the
initial whole-genome sequences of two individuals of West-
ern European descent. Since the Bentley et al. [20] and Wang
et al. [21] studies were added to the DGV after the design of
the CNV-typing array, the shorter regions discovered by
whole-genome sequencing of one of the Yoruba and an Asian
were not included. The CNV-typing array consists of approx-
imately 2.4 million 60-nucleotide long probes concentrated
at the known and putative CNVs, at variable spacing as close
as 10 bp apart.
Our arrays are essentially tiling designs with probe sequences
picked from the reference genome (build 36), and are more
similar to early BAC and Agilent CGH arrays than to recent
genotyping arrays, such as the Affymetrix SNP 6.0 or the Illu-
mina BeadChips, which generate allele-specific signals (with
the exception of subsets of non-genotyping copy number
probes). To observe copy number events on our arrays, we
processed our probe signals with circular binary segmenta-
tion (CBS) [22], a CNV detection algorithm originally devel-
oped for BAC arrays but also suitable for our tiling arrays.
Results
Whole-genome scan
DNA samples from each of the 90 Yoruba individuals was
whole-genome amplified, randomly fragmented, end-labeled
with biotin, and then hybridized to the three genome-scan
arrays (see Materials and methods). Probe signals were quan-
tile normalized [23] across the 90 individuals separately for
each design; then for each individual, changes in signal log
ratios based on median signals from > 90 arrays werehttp://genomebiology.com/2009/10/11/R125 Genome Biology 2009,     Volume 10, Issue 11, Article R125       Matsuzaki et al. R125.3
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detected as gain and loss events using CBS [22] (see Materials
and methods). Probes are sequentially inter-digitated across
the three genome-scan arrays, allowing the three arrays to be
treated as technical replicate experiments. Segments above or
below the detection thresholds must be observed in at least
two of the three designs before assigning a CNV event to an
individual. In total, 6,578 putative CNV regions were identi-
fied in the whole-genome scans of the 90 Yoruba, where a
putative region had at least one detected event among the
individuals; a subset of 3,850 regions showed events in at
least two individuals (Table 1). Based on the longest detected
events at each region, the putative CNVs had a median length
of approximately 4.9 kb, with 25th and 75th percentiles rang-
ing from 1.7 kb to 15.7 kb, respectively. In order to capture the
wide spectrum of CNV lengths, two separate segmentation
analyses were run: the first using all probes (no smoothing)
for the shorter ranges, and a secondary smoothed analysis to
fill out the longer ranges (see Materials and methods). The
median lengths were approximately 4 kb and approximately
70 kb, respectively, with the smoothed analysis accounting
for only approximately 11% of the putative CNVs (Table 1).
The length distribution of the putative CNVs is mostly sym-
metric about the median, but with a noticeable bias toward
longer lengths, and a smaller second peak reflecting the
longer regions from the smoothed segmentation analysis
(Figure 1). The genome locations (build 36) and estimated
lengths of the putative CNVs are listed in Additional data file
2.
Of the 3,850 putative CNVs having events observed in at least
two individuals (defined as high confidence), approximately
67% overlapped at least one record in the DGV (March 2009),
while only approximately 44% of the remaining regions hav-
ing an event in only one individual (singletons) overlapped a
DGV record (Table 1). Overlap is defined as greater than 5%
of a putative region coinciding with a DGV record, not includ-
ing inversions and records with lengths less than 100 bp. The
minimum requirement of 5% overlap with DGV records was
set low to accommodate a wide range of differences in resolu-
tions between previous studies and our genome-scan. Since
the union of DGV records (March 2009) covers a fair propor-
tion of the genome (approximately 30%), a > 5% overlap does
not necessarily validate a region, but serves as a starting point
for comparison with previous studies. The high resolution of
the genome-scan arrays revealed several instances of multiple
smaller CNVs lying within regions that were earlier reported
as one longer CNV in studies using lower resolution methods.
Two such examples are shown in Figure S2 in Additional data
file 1; the first is a 200-kb region with at least four CNVs and
the second is a 20-kb region with two CNVs. These example
regions overlap multiple DGV records from earlier studies
such as Redon et al. [12], and more recent higher resolution
studies such as Perry et al. [13]. The putative CNVs observed
in the 90 Yoruba more closely match the shorter DGV records
from the newer studies (Figure S2 in Additional data file 1).
To experimentally validate a sampling of the putative CNVs,
we randomly selected observed events between 400 bp and 10
kb for PCR or quantitative PCR (qPCR). PCR primers were
designed to amplify across putative breakpoints, while prim-
ers for qPCR were designed within gain regions. Figure 2
shows an example of loss events in two Yoruba DNAs,
NA19132 and NA19101, which appear as the shorter PCR
amplicons in the electrophoresis gel. The amplicon bands
were excised from the gel and sequenced to precisely map
breakpoints, which corresponded to identical 815-bp dele-
tions in both DNAs. This process was carried out at 18
regions, and breakpoints at 16 were successfully mapped
(Table S3 in Additional data file 1). Observed event lengths
closely matched the actual event lengths determined by
sequencing across breakpoints, which ranged from 593 to
2,085 bp (Figure 3). Eight of the 16 successfully sequenced
regions overlapped at least one record in the DGV (March
2009), and actual event lengths determined by PCR and
sequencing exactly matched (to within less than 3 nucle-
otides) 6 DGV records from sequencing-based studies (Figure
S3B in Additional data file 1). Out of 44 randomly selected
events for PCR, 4 failed to give specific amplicons, leaving 40,
of which 31 were successfully validated, while 6 were ambigu-
ous (77.5% to 92.5% validation rate; Additional data file 3).
These PCR results provided some assurance that the genome
scans had relatively low false discovery rates for CNV regions;
however, because of the stringent requirements applied to
call an event, a noticeable false-negative observation rate was
Length distributions Figure 1
Length distributions. The top two panels show the length distributions of 
putative and confirmed CNVs, respectively. The smaller second peak in 
the putative and to a lesser degree in the confirmed CNVs reflects the 
longer CNVs identified in the secondary smoothed segmentation analysis. 
For comparison, the approximately 1,300 CNVs reported in the 
McCarroll et al. [14] study, which used Affymetrix SNP 6.0 arrays on 270 
HapMap individuals including the 90 Yoruba, are shown in the bottom 
panel. Lengths are shown in log scale.
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also demonstrated. PCR tests were performed on Yoruba
DNAs selected in pairs, whereby an event was observed in one
DNA but not the other on the genome-scan arrays. However,
the patterns of bands in the PCR gels showed cases of actual
losses or gains in 'non-event' DNAs (Figure 2; Additional data
file 3). At three regions where truncated PCR amplicons from
'non-event' DNAs were excised and sequenced (including the
CNV shown in Figure 2), the deletions mapped to the exact
same breakpoints as in the event DNAs (Table S3 in Addi-
tional data file 1). For qPCR, out of16 selected gain events
tested, 9 were confirmed and 3 were ambiguous, but 4
showed clear evidence of homozygous deletions in the 'non-
event' DNA rather than gains in the 'event' DNA (Table S5 in
Additional data file 1). Similar to the gel based PCRs, the
qPCR results confirmed a fair proportion of putative regions,
but also demonstrated that event calls in many individuals
were missed.
Because the primary objective of the genome-scans was CNV
region discovery, we set stringent requirements for event
detection that prioritized low false discovery of regions at the
expense of sensitivity to observe sample level calls at those
regions. Once CNV regions had been identified in the genome
scans, we focused on designing a new array more suited to
generating sensitive and reliable sample-level calls, where
space on the genome-scan array originally occupied by addi-
tional array probes residing outside of CNV regions can now
be better used. To optimize array design parameters that
would increase sample-level call sensitivity, we designed a
small test array with variable probe lengths from 39 to 69
nucleotides, variable probe feature sizes, and 5 replicates of
each unique probe, at 150 arbitrarily chosen regions of which
105 were putative CNVs from the genome scan and the
remainder were records from the DGV. Filters were not
applied to the choice of probe sequences for the test array,
which included probes that overlapped any known repetitive
regions, including Alu elements. Results from a subset of 12
Yoruba individuals on the small test array suggested the use
of 60-nucleotide long probes at 5 micron pitch, with 3 repli-
cates per probe, and the inclusion of probes in repetitive
regions, with the exception of Alu elements (data not shown).
Probes on the test array corresponding to nearly all Alu ele-
ments were not responsive to copy number differences, while
probes at other repetitive regions had variable responses that
ranged from no change (similar to Alus), reduced response, or
full response (similar to non-repetitive regions), with no clear
correlation to the class of repeat elements (data not shown).
Based on the test array findings, the CNV-typing array was
designed to have higher sensitivity for event detection, and
includes probes corresponding to repetitive regions (other
Table 1
Summary of putative and confirmed CNVs
Putative 
CNVs
High conf Singleton CBS all 
probes
CBS 
smoothed
Confirmed 
CNVs
Confirmed 
high conf
Confirmed 
singleton
Parent set Putatives Putatives Putatives Putatives Putatives Putative high 
conf
Putative 
singleton
Number of 
CNVs
6,578 3,850 2,728 5,842 736 6,368 3,799 2,569
% of parent set 58.5% 41.5% 88.8% 11.2% 96.8% 98.7% 94.2%
Median length 4.9 kb 5.9 kb 3.7 kb 4.0 kb 70.7 kb 4.4 kb 5.3 kb 3.1 kb
25th 
percentile
1.7 kb 2.3 kb 1.1 kb 1.5 kb 48.5 kb 1.5 kb 2.1 kb 1.0 kb
75th 
percentile
15.7 kb 19.0 kb 12.0 kb 9.8 kb 105.9 kb 13.2 kb 16.8 kb 9.1 kb
DGV overlap 3,780 2,587 1,193 3,346 434 3,678 2,551 1,127
% DGV 57.5% 67.2% 43.7% 57.3% 59.0% 57.8% 67.1% 43.9%
Med len in 
DGV
6.6 kb 7.6 kb 4.5 kb 5.2 kb 77.0 kb 5.8 kb 6.8 kb 3.9 kb
Novel CNVs 2,798 1,263 1,535 2,496 302 2,690 1,248 1,442
Med len novel 3.4 kb 3.6 kb 3.2 kb 2.8 kb 64.5 kb 3.0 kb 3.2 kb 2.6 kb
Putative CNVs are regions where at least one event was observed in the initial genome scan; confirmed CNVs are a subset of putative CNVs where 
at least one event was observed on the CNV-typing array. 'High conf' (high confidence) refers to putative CNVs that had events observed in at least 
two Yoruba, while singletons are putative CNVs with observed events in only one Yoruba. 'CBS all probes' refers to putative CNVs identified in the 
segmentation analysis using all probes on the genome-scan arrays, while 'CBS smoothed' refers to generally longer CNVs identified in smoothed 
segmentation analysis. At least 5% of a CNV region was required to overlap a record from the DGV (March 2009). Med len, median length.http://genomebiology.com/2009/10/11/R125 Genome Biology 2009,     Volume 10, Issue 11, Article R125       Matsuzaki et al. R125.5
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than Alu elements). Using data from the CNV-typing array, a
thorough study of the possible relationships between repeat
elements and CNVs is also possible, but is beyond the scope of
the current work.
CNV genotyping
There were approximately 98,000 events observed at the
putative CNVs across the 90 Yoruba on the CNV-typing array.
Nearly 97% (6,368) of the putative CNV regions discovered in
the genome scans were confirmed to have at least one
observed event on the CNV-typing array (Table 1). The high
confidence putative CNVs had a higher confirmation rate of
approximately 99% compared to the singletons (approxi-
mately 94%), suggesting a degree of specificity in the region
confirmations. Integer copy number event calls, where 0 is
homozygous loss, 1 is one copy heterozygous loss, and 3 or
more are gain events, were based on CBS at thresholds deter-
mined by comparison to reference calls. The reference calls
were primarily from the McCarroll et al. [14] study, which
used the Affymetrix SNP 6.0 genotyping array to determine
event calls at approximately 1,300 CNVs in 270 individuals
from the HapMap Project [1], including the 90 Yoruba. The
validation PCRs (discussed above) were a secondary refer-
ence set. Comparisons with the reference calls provided a
measure of event sensitivity; and a subset of CNVs that had no
events among the Yoruba in the McCarroll et al. [14] study,
provided an estimate of event specificity (see Materials and
methods). Sample-level event calls in the 90 Yoruba individ-
uals at the confirmed CNVs, and at CNVs from the McCarroll
et al. [14] study, are listed in Additional data files 6 and 7,
respectively. Often an individual had two or more event seg-
ments within a putative region; this was either because event
Examples of loss events detected by segmentation analysis [22] in two Yoruba DNAs, NA19132 and NA19101, at putative CNV locus_id 3262 Figure 2
Examples of loss events detected by segmentation analysis [22] in two Yoruba DNAs, NA19132 and NA19101, at putative CNV locus_id 3262. PCR 
across the putative breakpoint of the events showed truncated bands from both DNAs, which were excised and sequenced. The sequences of the 
truncated amplicons were mapped on build 36 to determine the precise breakpoints, which corresponded to identical 815-bp deletions in both DNAs. 
Although the homozygous deletion in NA19132 was detected on the genome-scan arrays, the one copy loss in NA19101 was missed. The red lines in the 
log2 ratio plots indicate the segments detected by CBS. Although not shown, the results from the a- and c- genome-scan arrays were nearly identical to 
the b-design. The events in both DNAs, however, were detected on the CNV-typing array. The CNV-typing array showed no events in the preceding 
CNV locus_id, 3261, approximately 350 kb upstream on chromosome 9. The log2 ratio (y-axis) scales are different between the genome-scan array and 
CNV-typing array, and reflect a higher response in the latter.
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segments were split by intervening repeat elements, where
probes were not responsive to copy number differences, or
because the region is complex, having two or more smaller
CNVs within a narrow region. Split event segments within a
region were treated as one event call if the direction of the
multiple segments was consistently all loss or all gain in an
individual. On the other hand, complex regions were identi-
fied wherever a loss and gain event was observed within a
region in the same individual. Complex regions are annotated
in Additional data file 2. The positions of the confirmed CNVs
listed in Additional data file 2 are based on the first and last
positions of event segments detected among individuals.
The median length of the confirmed CNVs was 4.4 kb, which
was slightly shorter than the median length of the putative
C N V s  ( T a b l e  1 ) .  T h e  l e n g t h  d i s t r i b u t i o n  o f  t h e  c o n f i r m e d
CNVs is noticeably more symmetric about the median com-
pared to the lengths of the putative CNVs because many of the
overestimated lengths from the smoothed CBS analysis (sec-
ond peak in the putative distribution) have now been refined
downward (Figure 1). The distribution of the CNVs reported
in the McCarroll et al. [14] study, where the resolution of the
SNP6 array is estimated to be approximately 2 kb, starts at
approximately 1 kb and is similarly symmetric but is also
biased toward longer lengths (Figure 1). The approximately
58% of confirmed CNVs that overlapped DGV had a longer
median length of approximately 5.8 kb, while the 2,690
potentially new CNVs not reported in the DGV (6,368 con-
firmed minus 3,678 that overlap DGV) had a median length of
approximately 3.0 kb (Table 1). In cases where a confirmed
CNV overlapped with more than one DGV record, it was
paired with the closest matching record based on start and
end positions in genome build 36. A breakdown of the pair-
wise comparisons by the reported discovery methods is
shown in Figure 4. The lowest points in the plots reflect the
limiting resolution of the various methods; for example,
Array CGH is capped below at approximately 30 kb, while
whole-genome sequencing (Sequencing in Figure 4) is only
limited by the arbitrary minimum cutoff of 100 bp applied to
the DGV records. Length correlations were poorest with ear-
lier lower resolution methods, such as BAC arrays (Array-
CGH), and progressively better with regions identified by
higher resolution CGH arrays from Agilent (HiRes_aCGH)
and earlier SNP genotyping arrays, such as the Affymetrix
500 K and Illumina 550 BeadChip (SNP_Array_Early). The
SNP_Array_Early classification also includes shorter CNVs
identified by Mendelian inconsistencies and haplotype analy-
sis of SNP data from earlier arrays. Poor correlations in these
comparisons with earlier methods are generally instances
where our higher resolution arrays have refined the bounda-
ries of previously reported longer regions. The length correla-
tions were higher with pair-end sequence mapping analysis
(Seq_Mapping) and recent SNP arrays, namely the Affyme-
trix SNP 6.0 and Illumina 1 M BeadChip (SNP_Array). The
correlation with whole-genome sequencing (Sequencing in
Figure 4) was also high, but there was a noticeable subset of
regions where the reported DGV lengths are shorter and
likely overestimated in our work. The overlapping DGV
records were from 27 references [2,6,11-15,18-21,24-39] cited
in the DGV (Table S6 in Additional data file 1). CNV discovery
methods described in the previous studies were classified as
listed in Table S6 in Additional data file 1; the paired DGV
records for each of the overlapping confirmed CNVs are listed
in Additional data file 2. The pair-wise comparison does not
take into account the number of individual samples, or the
ethnicity of the individuals. Therefore, in addition to reflect-
ing the differences in resolution among the various discovery
methods, the correlation of lengths may be indicative of
actual population- or individual-specific differences in over-
lapping CNV regions.
In order to further compare our results with DGV records at
the individual sample level, we selected six recent studies,
including the McCarroll et al. [14] study, where event calls for
one or more Yoruba individuals were reported. The Korbel et
al. [31] and Kidd et al. [30] studies were based on pair-end
mapping of sequencing reads from one and four Yoruba indi-
viduals, respectively; in the Bentley et al. [20] study, one of
the Yoruba was whole-genome sequenced; the Perry et al.
[13] study examined known copy number variants in 10
Yoruba using Agilent microarrays; and in the Wang et al. [15]
study, 36 Yoruba were genotyped using Illumina BeadChips.
For each Yoruba individual in common between our work and
a previous study, events were matched based on the longest
overlap at genome build 36 pos i t i o n s .  E v e n t s  i n  c o m p l e x
regions were not included in these comparisons. Event calls
reported in the six studies along with the corresponding
Results of breakpoint mapping by sequencing are compared with observed  event lengths Figure 3
Results of breakpoint mapping by sequencing are compared with observed 
event lengths. Lengths are shown in linear scale.
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genome build 36 positions are listed in Additional data file 8.
Due to differences in the resolution of the methods, one
reported event could match many events observed in our
work, and vice-versa. Table 2 lists two sets of comparisons for
each study because of these many-to-one and one-to-many
matches. The number of observed or reported events in the
common Yoruba, and the percentage of these events that were
matched and compared, give an indication of the extent of
missed events in either our work or the previous studies.
Although we report integer copy number calls, some of the
studies report events as either loss or gain; in order to sim-
plify the comparisons, we treat integer 0 and 1 copy calls as
loss, and 3 or more copy calls as gains. For each Yoruba in
common between two sets of calls, we tally pair-wise
instances of agreement in the direction of the events, and
count disagreements whenever a loss in one set is matched to
a gain in the second set, or vice-versa. Sample-level compari-
sons among pairs of previous studies showed varying degrees
of agreement in the direction of calls, and in the numbers of
matched regions in common (Table S6 in Additional data file
1). Similarly, the events observed in our work had varying
degrees of call agreement and region counts in common with
the previous studies (Table 2). For example, the Bentley et al.
[20] study, which was based on whole-genome sequencing,
reported over 4,000 events in the one Yoruba; our work
observed approximately 800 events in the same individual, of
which only approximately 330 events were in common, with
only approximately 93% of these calls in agreement (Table 2).
In contrast, the Wang et al. [15] study, which was based on
Illumina SNP genotyping BeadChips, reported only approxi-
mately 1,200 events among 36 Yoruba (approximately 30 per
individual) compared to > 40,000 events (approximately
Pair-wise comparison of lengths Figure 4
Pair-wise comparison of lengths. The lengths of confirmed CNVs from our work are compared with the closest matching DGV records subdivided by six 
classifications of CNV discovery methods. The lowest points in the panel sub-plots reflect the limiting resolution of the method classes. Data points above 
the diagonals represent instances where our higher resolution survey has refined the boundaries of previously reported longer regions, while points below 
the diagonals are cases where lengths are likely overestimated in our work. Lengths are shown in log scale. Methods from 27 references cited in the DGV 
(March 2009) were classified (listed in Table S6 in Additional data file 1).
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1,000 per individual) in our work; but of the > 800 events that
were in common, the direction of > 99% of the calls were in
agreement with our work (Table 2).
Since the 90 Yoruba are each members of 30 family trios, we
examined the inheritance of events from parents to children.
The majority of copy number polymorphisms are inherited
[32], rather than rare de novo occurrences [14]. The observa-
tions of events in children but not in either of the parents are
due to false-positive observation in the child, or false-nega-
tive detection in either or both of the parents, with only a very
small proportion likely to be true de novo events. The approx-
imately 98,000 event calls at 6,368 confirmed CNVs across
the 90 Yoruba were grouped by the 30 family trios. Of the
total observed events, approximately 10,500 (10.8%) were
observed in only the children of trios. The same 30 trios were
also part of the McCarroll et al. [14] study, in which there
were approximately 7,800 reported events (along with
approximately 1,600 no_calls) at 859 CNVs in the Yoruba, of
which only 25 (0.3%) events were observed in only the chil-
dren. The 36 Yoruba genotyped in the Wang et al. [15] study
are members of 12 of the trios, in which approximately 1,110
events were reported, of which 13 (1.2%) were observed only
in children. The event calls in the McCarroll et al. [14] study
benefited from having two fully replicated data sets of 270
individuals run independently in separate laboratories, as
well as manual curation of scatter plots that were used to clus-
ter the samples into estimated copy number classes. The sen-
sitivity and specificity of event calls in the Wang et al. [15]
study benefited from the direct use of the family trio informa-
tion in the calling algorithm, which markedly reduced the
observations of what Wang et al. referred to as CNVs inferred
in offspring but not detected in parents (CNV-NDPs).
In order to delineate the observations of false positives in
children and false negatives in parents in our work, the trio
event calls from the McCarroll et al. [14] and Wang et al. [15]
studies were used for a three-way comparison. For each of
three comparisons, two of the three data sets were used to cre-
ate a consensus reference set of event calls from the 12 trios
common to the three sets. To reduce the probability of any
spurious singleton calls in the reference set, we included only
event instances seen at least twice in a given family. The
occurrence of false-negative and false-positive event calls in
the third data set not in the consensus reference was tallied as
shown in Table 3; the individual trio calls in the three com-
parisons are listed in Additional data file 4. The event calls in
our work had a comparable but slightly higher false-positive
observation rate (specificity) than the two other studies, but a
noticeably higher false-negative detection rate (lower sensi-
Table 2
Comparison of Yoruba event calls
Study (method) Common 
Yoruba
% call 
agreement
Events 
compared
Events in 
study
% study 
compared
Events in our 
work
% our work 
compared
Bentley et al. 2008 1 92.6% 338 4,103 8.2%
(Sequencing) 93.6% 326 792 41.2%
Kidd et al. 2008 4 92.1% 316 944 33.5%
(Seq_Mapping) 93.1% 320 4,680 6.8%
Korbel et al. 2007 1 87.4% 199 732 27.2%
(Seq_Mapping) 87.0% 200 903 22.1%
McCarroll et al. 2008 90 99.7% 5,442 7,752 70.2%
(SNP_Array) 99.6% 5,699 97,745 5.8%
Perry et al. 2008 10 89.5% 1,403 6,695 21.0%
(HiRes_aCGH) 89.9% 1,344 10,951 12.3%
Wang et al. 2007 36 99.3% 814 1,156 70.4%
(SNP_Array_Early)
99.2% 869 40,739 2.1%
Event calls at confirmed CNVs were compared with events reported in six recent studies that included one or more Yoruba individuals. For each 
Yoruba in common, events were matched based on the longest overlap. Because of differences in resolution among methods, an event at a confirmed 
CNV could match many reported events, and vice-versa. For each study, the numbers of compared events differ slightly depending on whether our 
event calls were compared against study events, or vice versa. Agreement was determined by comparing loss versus gain events, and not integer 
copy numbers. The percentage of events that overlapped reflects the relative degree of missed events in either our work or the previous study.http://genomebiology.com/2009/10/11/R125 Genome Biology 2009,     Volume 10, Issue 11, Article R125       Matsuzaki et al. R125.9
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tivity) (Table 3). The breakdown of rates in our work, 9.6%
false negative versus 1.5% false positive, indicates that the
majority of the approximately 10.8% of total events observed
only in the children of trios was due to missed events in the
parents rather than spurious false observations in the chil-
dren. Because of the higher resolution of the CNV-typing
array, the false-positive rate of our work may be slightly over-
estimated, particularly in instances where neighboring
smaller CNVs from our work were compared with one larger
reported CNV from the studies. One such example occurred
in one of the trios, trio_id 5, at locus_ids 3804 and 3805,
which are separated by approximately 15 kb on chromosome
10. These two CNVs from our work were compared with sin-
gle overlapping larger DGV records: variation_9648 or
variation_37784, from the Wang et al. [15] and McCarroll et
al. [14] studies, respectively (Additional data file 4A). Our
work showed loss at locus_id 3804 and gain at locus_id 3805,
while both studies called gain in the corresponding larger
region. The loss calls at the smaller locus_id 3804 are tallied
as disagreements in Table 3; however, our higher resolution
array indicates that the loss event was passed from father to
child in this trio (Additional data file 4A), which raises the
possibility that these events may have been missed in the two
studies.
Events at CNVs discovered by whole-genome 
sequencing
The CNV-typing array has probes corresponding to shorter (<
1  k b )  C N V s  d i s c o v e r e d  b y  s e quencing individual genomes
[18,19], enabling estimates of event frequencies at these CNVs
in our Yoruba samples. DGV records with lengths < 1 kb are
classified as indels, but for our array design we included
records down to an arbitrary cutoff of 100 bp, and consider
these longer indels as shorter CNVs. Probes on the CNV-typ-
ing array corresponding to regions from the Levy et al. [18]
and Wheeler et al. [19] studies were grouped as
Levy+Wheeler, corresponding to regions in common between
the two studies, or Levy_only or Wheeler_only, correspond-
ing to regions reported in only one of the studies (Table 4).
Sample-level calls at the three groups of regions from the
Levy et al. [18] and Wheeler et al. [19] studies are listed in
Additional data file 7. Regions from the two studies that over-
lapped any of the putative CNVs from our genome-scan were
excluded. The overlap between putative CNVs, and regions
from the Levy et al. [18] and Wheeler et al. [19] studies was
only 9% and 22%, respectively. In contrast, there was 91%
overlap with 859 CNVs (median length of 7.4 kb), with at least
one reported event in a Yoruba from the McCarroll et al. [14]
study.
A large majority (> 77%) of the shorter CNVs that were dis-
covered by sequencing individuals of Western European
descent had at least one observed event in the Yoruba (Table
4). Based on detected events across the 90 Yoruba, the
median lengths were 190 bp and 240 bp in the Levy_only and
Wheeler_only groups, respectively (Table 4), and the length
distributions of these regions were skewed toward the 100-bp
cutoff (Figure 5). Bearing in mind that observed frequencies
may be underestimated due to missed event calls as suggested
by the trio analysis above, the three groups of regions had
noticeably higher event frequencies compared to the 6,368
confirmed CNVs from our work, as measured by average
events per region, or cumulative events in the 90 Yoruba
(Table 4, Figure 6). But a subset of 1,107 confirmed CNVs
from our work, having lengths < 1 kb, had similar high event
frequencies, and cumulative events, resembling the
Table 3
Three-way comparison of event calls in trios
Confirmed loci McCarroll et al. (2008) Wang et al. (2007)
Reference events 428 338 348
Calls compared 387 90.4% 328 97.0% 329 94.5%
False negatives 41 9.6% 10 3.0% 19 5.5%
Missed loss 18 7 15
Missed gain 23 3 4
Agree with reference 384 99.2% 328 100.0% 329 100.0%
Disagree 3 0.8% 0 0.0% 0 0.0%
Called events 393 331 333
False positves 6 1.5% 3 0.9% 4 1.2%
Twelve Yoruba family trios are common to the Wang et al. [15] and McCarroll et al. [14] studies, and our work. For each comparison, two of the 
three data sets were used to create a consensus reference. Consensus among the references and agreement with the references were determined 
by comparing loss versus gain events, and not integer copy numbers. The sample-level calls in each of the three comparisons are listed in Additional 
data file 4.http://genomebiology.com/2009/10/11/R125 Genome Biology 2009,     Volume 10, Issue 11, Article R125       Matsuzaki et al. R125.10
Genome Biology 2009, 10:R125
Levy_only group (Figure 6). The cumulative event curves are
distinctly different between the Levy_only and Wheeler_only
groups, with the Levy+Wheeler curve intermediate between
the two. Increasing the specificity of event calls (lowering
false-positive events at the expense of sensitivity) noticeably
lowered event frequencies in the Levy_only group, and to a
lesser degree in the < 1 kb confirmed CNVs from our work, but
the Levy+Wheeler and Wheeler_only groups maintained
high relative event frequencies (Figure 7). The occurrence of
loss events was higher than gain events at the confirmed
CNVs, but to a lesser degree in the Wheeler_only group, and
even less so in the Levy_only and Levy+Wheeler groups
(Table 4). For comparison, in previous studies the ratio of
loss:gain in Yoruba ranged from 6.3, 3.5, 2.5, to 0.9, and 0.9
in the McCarroll et al. [14], Korbel et al. [31], Wang et al. [15],
Perry et al. [13], and Kidd et al. [30] studies, respectively. In
total, we generated sample-level event calls in the 90 Yoruba
at nearly 9,000 regions (approximately 4% of genome),
including > 3,300 shorter regions (< 1 kb). A breakdown of
event occurrence by region lengths shows that event frequen-
cies were higher in subsets of shorter (< 1 kb) CNVs from both
our work or the Levy et al. [18] and Wheeler et al. [19] studies
(Figure 8).
Discussion
That our high resolution genome scans of the 90 Yoruba
uncovered as many as 2,690 potentially new CNVs with a
median length of approximately 3.0 kb suggests that there are
many more CNVs yet to be discovered on the shorter end of
the size range. Because of the high resolution of our genome-
Table 4
Summary of events at CNV regions discovered by sequencing
Confirmed CNVs Confirmed < 1 kb Levy + Wheeler Levy_only Wheeler_only
Reported CNVs 221 1,753 957
with YRI events 6,368 1,107 172 1,651 740
% with events 77.8% 94.2% 77.3%
Median length 4,380 bp 490 bp 193 bp 190 bp 240 bp
25th percentile 1,519 bp 290 bp 110 bp 120 bp 120 bp
75th percentile 13,230 bp 735 bp 849 bp 380 bp 974 bp
Events 97,953 27,718 4056 40,968 13,968
Events per region 15.4 25.0 23.6 24.8 18.9
Homozygous loss (0) 5,792 2,177 321 1,004 1,092
One copy loss (1) 55,593 14,335 1,792 20,353 6,882
One copy gain (3) 31,198 9,082 1,415 16,926 4,879
Multiple gains (4+) 5,370 2,124 528 2,685 1,115
Loss:gain 1.7 1.5 1.1 1.1 1.3
Regions are from the Levy et al. [18] and Wheeler et al. [19] whole-genome sequencing studies. Levy+Wheeler refers to regions common to both 
studies, while Levy_only and Wheeler_only are regions reported only in either study. Regions that overlap any of the putative CNVs from the 
genome-scan were not included in these three sets. Reported refers to the numbers of CNVs discovered in the studies. 'With events' is the tally of 
reported regions having at least one observed event on the CNV-typing array, and 'events' is the tally from all 90 Yoruba at all regions. The events 
are broken down by tallies of integer copy number calls, where 0 is homozygous loss, 1 and 3 are heterozygous loss and gain, and 4+ is the tally of 
multiple gains. 'Loss:gain' is the ratio of loss and gain event tallies.
Length distributions of CNV regions discovered by sequencing Figure 5
Length distributions of CNV regions discovered by sequencing. Lengths of 
regions as summarized in Table 1 with an event in at least one Yoruba. 
Lengths are shown in log scale.
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scan arrays, we were able to delineate neighboring multiple
smaller CNVs at regions earlier reported as single larger
CNVs, as illustrated in Figure S2 in Additional data file 1.
Perry et al. [13] observed and validated other such instances
of multiple CNVs in close proximity, and describe these cases
as architecturally complex CNV regions. The tight correlation
between observed event lengths and actual lengths deter-
mined by PCR and breakpoint sequencing (Figure 2b) reflects
fairly accurate breakpoint mapping of events in the approxi-
mately 1 to 2 kb range, and suggests, by extrapolation, accu-
racy in longer ranges. Of the 16 CNVs confirmed by PCR and
breakpoint sequencing, six were exact matches to DGV
records reported by sequencing-based methods (Table S3 in
Additional data file 1). Specifically, three of the six matched
Cumulative event occurrence across the 90 Yoruba Figure 6
Cumulative event occurrence across the 90 Yoruba. The region groups are summarized in Table 4. The numbers of regions in each group are scaled to 1.
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Similar cumulative event occurrence when applying a more stringent event threshold of 0.35 compared to 0.175 in Figure 6 Figure 7
Similar cumulative event occurrence when applying a more stringent event threshold of 0.35 compared to 0.175 in Figure 6. Under the stringent threshold 
where fewer events were observed, approximately two-thirds of the regions summarized in Table 4 showed at least one event: 4,733 of confirmed CNVs, 
and 107, 1,153, and 411, of Levy+Wheeler, Levy_only, and Wheeler_only regions, respectively.
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records from the Mills et al. [2] study, which mapped publicly
available sequencing trace data, two matched records from
the Wheeler et al. [19] study, which whole-genome sequenced
an individual of Western European descent, and one matched
a record from the Bentley et al. [20] study, which sequenced
a different Yoruba. These are instances of the same exact
events occurring in different individuals of varying ethnici-
ties, and likely represent older CNVs that have taken root in
the genome. The whole-genome sequencing data generated
by sequencing more individua l s ,  s u c h  a s  i n  t h e  1 0 0 0
Genomes Project, will undoubtedly produce a more thorough
catalog of shorter CNVs in the genome, including an assess-
ment of the age of these variations.
Even at a resolution of approximately 200 bp, our genome
scan detected only a fraction of the CNVs reported in whole-
genome sequencing studies (Levy et al. [18] and Wheeler et
al. [19] studies at 9% and 22%, respectively). Our inability to
detect shorter (< 1 kb) CNVs shows one limitation of using
microarrays, although continued advances in array manufac-
turing technology could further increase array probe density
in the future. In the meantime, a viable approach is to rely on
DNA sequencing for CNV region discovery in limited num-
bers of samples, and follow up with microarrays for localized
sample-level event detection across larger sample sets as we
have done here. Shorter (< 1 kb) regions that were identified
in our genome-scan, such as the example shown in Figure 2,
were often instances of homozygous deletions, which mani-
fest stronger event segments. In contrast, one-copy-loss
events give weaker segments that were often missed, but are
likely to occur more frequently than homozygous deletions.
These instances of false-negative CNV discovery, particularly
in shorter regions with rare event frequencies, could be miti-
gated by using an improved genome-scan array design with
longer probes and the inclusion of multiple replicates of each
p r o b e ,  j u s t  a s  w e  h a v e  d e m o n s t r a t e d  f o r  t h e  C N V - t y p i n g
array. In contrast, the higher overlap (91%) between putative
CNVs and the generally longer CNVs (median length approx-
imately 7.4 kb) from the McCarroll et al. [14] study suggests
that the genome scan captured a fair proportion of CNVs > 1
kb. We were able to observe events at approximately 97% of
the putative CNVs from the genome scans on the CNV-typing
array. The low false-positive rate of putative CNVs on the typ-
ing array, and the fairly successful PCR validation, are con-
sistent with the stringent requirement of having had to
observe events in at least two of three genome-scan array
Breakdown of event occurrence tallies by region lengths Figure 8
Breakdown of event occurrence tallies by region lengths. Panels correspond to confirmed CNVs from our work, and regions discovered by whole-genome 
sequencing as summarized in Table 4. Box-plots show medians and interquartile ranges, with whiskers extending to maximum or minimum values within 
1.5 times the 75th or 25th percentiles, respectively. The width of boxes is proportional to the number of regions.
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designs, which served as technical replicates. To reduce noise
from probe to probe intensity variations, the CNV-typing
array has each unique probe placed in triplicate at scattered
locations on the array, and the signals from the triplicate
probes were summarized by median polish. The example seg-
mentation results shown in Figure 2 illustrate the reduction
i n  n o i s e  o n  t h e  t y p i n g  a r r a y .  I n  a d d i t i o n  t o  t h e  t r i p l i c a t e
probes, the CNV-typing array has improved sensitivity for
event detection by the use of 60-nucleotide long probes com-
pared to non-replicated 49-mer probes on the genome scan
arrays.
The disparity in agreement of sample-level event calls and
matched regions between our work and previous studies
(Table 2) may be due to sampling differences, which ranged
from only one Yoruba individual in common up to 90 individ-
uals; but more likely reflects underlying differences in specif-
icity and sensitivity, as well as genome coverage biases
inherent in the various methods, as well as in our work. These
differences are also apparent in pair-wise comparisons
among the six previous studies (Table S6 in Additional data
file 1), and point to the difficulty in determining absolute
accuracy and event call completeness. An examination of the
inheritance of events from parents to children among the
Yoruba trios in our work, along with events reported among
trios in the McCarroll et al. [14] and Wang et al. [15] studies,
provided an assessment of false-positive and false-negative
rates of event detection. Although slightly higher, the specifi-
city of event detection on the CNV-typing array was compara-
ble to the previous studies, and may be underestimated
because of the higher resolution; on the other hand, the sen-
sitivity to detect events was noticeably lower (Table 3). The
majority of events observed only in the children of trios were
due to missed events in the parents. The sensitivity could
improve with the availability of additional and replicate data
sets and manual curation of intermediate results, or the use of
family trio information, as was likely the case in the McCarroll
et al. [14] and Wang et al. [15] studies, respectively. That
these two previous studies also showed varying degrees of
false negatives and false positives, and the low proportion of
CNVs in common between the Levy et al. [18] and Wheeler et
al. [19] sequencing studies (Table 4), reinforces the benefit of
building a consensus from multiple studies. As more sample-
level data become available, particularly from whole-genome
sequencing and higher resolution microarray-based studies,
many of the discrepancies in the inter-reference comparisons
(Table 2; Table S6 in Additional data file 1) should be resolved
through higher confidence consensus among methods and
studies.
Events observed in the 90 Yoruba showed higher frequencies
at shorter CNVs compared to longer CNVs (> 1 kb; Figure 8).
The higher frequencies are consistent with expectations that
events in shorter regions are under less selective pressure
than at longer regions, which are more likely to be deleterious
[40]. The differences in the cumulative event frequencies,
even under stringent specificity thresholds (Figures 6 and 7),
are likely a reflection of differences in the di-deoxy and 454
polony sequencing methods used in the Levy et al. [18] and
Wheeler et al. [19] studies, respectively, and suggest that the
CNV-typing array is sensitive to detect some subtle character-
istic differences inherent in the regions discovered in the two
separate studies.
Conclusions
Recent studies using high resolution microarrays and whole-
genome sequencing have made major inroads toward a com-
plete catalog of CNVs in the human genome. Our work dem-
onstrated the use of even higher resolution microarrays to
uncover approximately 2,700 potentially new CNVs, and to
observe events in 90 Yoruba at regions discovered by whole-
genome sequencing of single individuals. The approximately
3,300 shorter regions (< 1 kb) examined in our current work
are likely just a fraction of what will eventually be discovered
through sequencing more individuals. In the near term, high
resolution microarrays offer a cost-effective means to confirm
these shorter CNVs, and type large numbers of individuals in
order to gain biological insights beyond the initial discovery.
Materials and methods
Array synthesis
Arrays were synthesized following standard Affymetrix Gene-
Chip manufacturing methods utilizing contact lithography
and phosphoramidite nucleoside monomers bearing photola-
bile 5'-protecting groups. Fused-silica wafer substrates were
prepared by standard methods with trialkoxy aminosilane as
previously described [16]. An improved 5'-protecting group
provided for more efficient photolysis and chain extension,
and therefore fewer truncated probe sequences [17]. The
genome-scan arrays and CNV-typing array required 141 and
179 synthesis steps, respectively, resulting in 3'-immobilized
DNA probes of 49 and 60 nucleotides in length. After the final
lithographic exposure step, the wafer was de-protected in an
ethanolic amine solution for a total of 8 hours prior to dicing
and packaging.
Array designs
Candidate 49-mer probe sequences for the three genome-
scan array designs were chosen from the non-repetitive
regions of the genome, and filtered for extraneous matches to
the genome in the central 16 nucleotides, resulting in a total
of 32 million unique probes. Rather than placing probes
sequentially across the three arrays, probes were dispersed
such that every second and third probe against the genome
was placed on separate arrays (Figure S1A in Additional data
file 1). Because of the inter-digitating of probes across the
three designs, the inter-probe interval in any one design
between the center positions of neighboring probes is gener-
ally 147 bp (the combined length of three probes). However,
because probes were filtered out at repetitive regionshttp://genomebiology.com/2009/10/11/R125 Genome Biology 2009,     Volume 10, Issue 11, Article R125       Matsuzaki et al. R125.14
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throughout the genome the overall median interval between
neighboring probes on the genome-scan arrays is 196 bp.
The CNV-typing array design consists of approximately
800,000 unique probes, with each in triplicate for a total of
approximately 2.4 million 60-mer probes. The replicate
probes are placed in separated locations on the array to miti-
gate any regional variations in signals. The approximately
800,000 unique probes are organized into approximately
16,000 partitions, each containing up to 50 unique probes.
The probe partitions correspond to putative or reported CNV
boundaries. The probes within a partition are evenly spaced
along chromosomes, with the exception of regions corre-
sponding to Alu elements and occurrences of high allele fre-
quency SNPs. In order to mitigate any potential
compounding effects on signals, probes with a common SNP
(minor allele frequency > 0.05) in the HapMap repository
[41] within the central 30 nucleotides were not allowed. In
contrast to the genome-scan arrays where probes in repetitive
elements were mostly filtered out, the CNV-typing design has
probes in all repeat regions other than Alu elements. The clos-
est spacing between the central positions in the 60-mer
probes is 10 bp apart. For CNVs shorter than 500 bp, the par-
tition will contain less than 50 unique probes; for example, a
300 bp region will have 30 overlapping probes with center
positions spaced 10 bp apart. For CNVs longer than 500 bp,
the 50 probes will be spaced further apart; for example, a
3,000 bp CNV will have 50 probes lined end-to-end, with no
overlap between 60-mer probes. Partitions corresponding to
shorter CNVs discovered by whole-genome sequencing of
individual genomes [18,19] were prioritized and assigned
first, followed by putative CNVs from the genome scan, and
then supplemented with regions that overlapped in at least
two records in the DGV (November 2008) (Figure S1B in
Additional data file 1). Because shorter CNVs were assigned
first, the shorter CNVs tend to have the highest probe density.
A longer CNV that overlaps a shorter CNV will be represented
by two partitions with different probe densities. In this way, a
partition can map to one or more CNV regions; conversely, a
CNV can be represented by one or more probe partition (Fig-
ure S1B in Additional data file 1). The probe sequences and
build 36 chromosome positions of all the four array designs
are available at ArrayExpress [42] under accession number E-
TABM-838.
Yoruba samples
The 90 Yoruba individuals are from the HapMap Project [1];
genomic DNA samples were obtained as immortalized cell
line isolates from the Coriell Institute [43]. During initial
analysis of the genome scans, unusually high occurrences of
gain events in chromosome 12 from NA19193, and chromo-
some 9 from NA19208 were observed (Figure S3 in Addi-
tional data file 1). These observations are consistent with
lymphoblastoid cell line artifacts that have been previously
reported in these two samples [12,44]. Data from these two
chromosomes were excluded from all subsequent segmenta-
tion analyses.
Sample preparation
Whole-genome amplification of genomic DNA samples was
performed using the REPLI-g Midi kit (Qiagen, Valencia, CA,
USA) following manufacturer-supplied instructions, starting
with 200 ng of input DNA in a 60 μl reaction. Amplified DNA
was randomly fragmented by controlled partial digestion with
DNase I. The optimal DNA target length for hybridization to
the arrays was found to be in the range of 50 to 300 bp, with
the majority of fragments at 100 to 200 bp. DNaseI at 2.5 U/
μl (Affymetrix, Santa Clara, CA, USA) was freshly diluted in
10 mM Tris pH 8 to a concentration of 0.3 U/μl; 3 μl of the
diluted DNaseI was added to 60 μl of amplified DNA and 7 μl
Fragmentation buffer (Affymetrix) at 37°C. To achieve the
optimal size range, test fragmentation time courses were first
performed using a small amount of the amplified DNA sam-
ples, where the incubation varied from 4 to 26 minutes. Fol-
lowing fragmentation, the amplified DNA was ethanol
precipitated and resuspended in 33.5 μl water; 1 μl was
removed to measure concentration, which was typically
approximately 1.5 μg/μl. The fragmented DNA was then end-
labeled with biotin using 2.5 μl of 30 mM DNA labeling rea-
gent (Affymetrix) and 5 μl of Terminal Transferase (Affyme-
trix) in a 50 μl reaction, which included 10 μl of 5× TdT buffer
(Affymetrix). Labeling reactions were incubated for 2 hours at
37°C until heat inactivation at 95°C for 10 minutes.
Hybridization to arrays
The labeled DNAs were hybridized to each array in 200-μl
volumes. In addition to 15 μl of approximately 1 μg/μl labeled
DNAs, the hybridization solution contained 100 μg denatured
Herring sperm DNA (Promega, Madison, WI, USA), 100 μg
Yeast RNA (Ambion, Austin, TX, USA), 20 μg freshly dena-
tured COT-1 DNA (Invitrogen, Carlsbad, CA, USA), 12% for-
mamide, 0.25 pM gridding oligo (Affymetrix), and 140 μl
hybridization buffer, which consists of 4.8 M TMACl, 15 mM
Tris pH 8, and 0.015% Triton X-100. Hybridizations were
carried out in Affymetrix ovens for 40 hours at 50°C with
rotation set at 30 rpm. Following hybridization, arrays were
rinsed twice, and then incubated with 0.2× SSPE containing
0.005% Trition X-100 for 30 minutes at 42°C with rotation
set at 15 rpm. The arrays were rinsed and filled with Wash
buffer A (Affymetrix). Staining with streptavidin, R-phyco-
erythrin conjugate (Invitrogen) and scanning with the
GCS3000 instrument (Affymetrix) were performed as
described in the Affymetrix GeneChip SNP 6.0 manual [45].
PCR and sequencing
A sampling of putative CNVs in pairs of Yoruba samples was
selected where an event was observed in one DNA but not the
other (Additional data file 3 and Table S5 in Additional data
file 1). For standard PCR, putative CNVs having an event seg-
ment within a sample in the range 400 bp to 2.5 kb were
tested; for quantitative PCR, CNVs having gain segmentshttp://genomebiology.com/2009/10/11/R125 Genome Biology 2009,     Volume 10, Issue 11, Article R125       Matsuzaki et al. R125.15
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between 500 bp and 10 kb were tested. Primer sequences for
standard PCR were designed from 300-bp candidate regions
upstream or downstream of the longest event segments
within a sample, and for qPCR, from within the shortest gain
segment. Candidate regions having less than 50% Repeat-
Mask (UCSC) were processed in either Primer3 [46] or
PrimerExpress 3.0 (Applied Biosystems, Foster City, CA,
USA) for standard or qPCR primer design, respectively.
Primer sequences are listed in Additional data file 5. Standard
PCRs using Advantage LA polymerase (Clontech, Mountain
View, CA, USA) and 400 nM primers (synthesized by IDT
Integrated DNA Technologies, Coraville, IA, USA) started
with 100 ng sample DNA. Following denaturation at 94°C for
1 minute, reactions were cycled 30 times as follows: 94°C for
30 seconds, 58°C for 30 seconds, and 72°C for 3 minutes, with
a 72°C final hold for 7 minutes. Amplicons corresponding to
loss events were excised from agarose gels, and sequenced
using either of the PCR primers. CNV loss breakpoints were
determined by mapping the amplicon sequences to genome
build 36 with BLAT [47] (UCSC). An Applied Biosystems
7300 machine was used for quantitative PCRs, according to
the manufacturer's instructions. Typically, the reactions
included SYBR Advantage 2× qPCR mix (Clontech), 200 nM
primers, 500 nM ROX reference (Roche, Indianapolis, IN,
USA), and 90 ng sample DNA. Following denaturation at
95°C for 30 seconds, reactions were cycled 40 times as fol-
lows: 95°C for 5 seconds and 60°C for 34 seconds.
Data processing
Signal intensities were quantile normalized [23] in sets of >
90 samples for each of the 3 genome-scan chip designs, or in
two separate sets of 45 samples for the CNV-typing design.
The triplicate probes on the CNV-typing array were summa-
rized by median polish. For probes on autosomal chromo-
somes, median signals were calculated using all samples,
while for probes on chromosome X and chromosome Y only
female or male samples were used, respectively. Two to five
additional non-Yoruba samples were part of the normaliza-
tion and calculation of medians in the genome-scan, but were
not included in subsequent analyses. The medians were the
basis of log2 ratios for segmentation analysis. In the initial
analysis of the genome-scans, a small subset of samples had
disproportionately high occurrences of apparent gain or loss
events. These artifact events were no longer observed after fil-
tering out probes with GC content > 0.6, and by applying a
sample-specific correction to the log2 ratios. The corrected
log2 ratios were derived in the following manner: for each
probe, calculate the GC content of its surrounding 50 kb
region; sort the GC content values into 50 equal size bins;
within each sample, for each bin, calculate the median of the
log2 ratios for all probes with GC content in that bin; correct
the log2 ratios in that sample by subtracting off the medians
derived in the prior step. Figure S4A in Additional data file 1
shows an example of artificially high log2 ratio values corre-
sponding to probes with high GC content in one of the sam-
ples with artifact gain events. The benefit of the filtering and
correction to the segmentation analysis is illustrated in Figure
S4B in Additional data file 1. Similar benefits of probe filter-
ing and correction have been reported in copy number analy-
sis using other arrays [48,49].
Segmentation: genome scan
CBS [22] was implemented in the R package DNAcopy [50].
For each sample and each genome-scan design, sets of 750
probes (approximately 150 to 200 kb windows) were analyzed
using signal from all probes (without smoothing) to specifi-
cally look for CNVs shorter than 100 kb. To identify longer
CNVs, segmentation analysis was performed with signal
smoothing using Nexus Rank Segmentation (BioDiscovery,
El Segundo, CA, USA), a proprietary algorithm based on CBS.
The smoothed segmentation was run on entire chromosomes.
Signals were smoothed by averaging eight consecutive
probes. The level of smoothing was chosen based on chromo-
some X receiver operating characteristic (ROC) analyses that
compared smoothing with 2 probes up to 256 probes (Figure
S5B in Additional data file 1). Initially, consecutive inter-digi-
tated probes from the three genome-scan arrays were com-
bined to get the highest possible resolution, up to 49 bp in
non-repetitive regions. However, the ROC analysis in Figure
S5B in Additional data file 1 shows lower sensitivity and spe-
cificity when combining the three designs, compared to using
probes from only one design (Figure S5A in Additional data
file 1). Averaging the combined probes from the three designs
(smooth 3 in Figure S5B in Additional data file 1) appears to
have comparable performance to the unsmoothed curve
using only one of the array designs (all probes in Figure S5A
in Additional data file 1). However, actual segmentation anal-
ysis from averaging three probes combined from the three
designs resulted in a highly disparate range of event tallies in
individual samples, indicative of false positives. Although
using probes from only one design at a time entailed a lower
resolution (at best 147 bp) in the genome scan, segmentation
was computed separately for each design. By using the three
genome-scan designs as technical replicates instead of in
combination, lower rates of false discovery (higher specifi-
city) was prioritized over higher resolution and sensitivity to
detect shorter CNVs.
For both non-smoothed and smoothed segmentation analy-
ses, gain and loss event thresholds were set to segment mean
log2 ratios of > 0.25 and <-0.25, respectively. For each sam-
ple, overlapping segments from at least two of three chip
designs was required to meet the thresholds in order to call a
gain or loss. The boundaries of an individual event were
defined by the longest overlap between any two event seg-
ments meeting the threshold. A putative CNV was defined as
regions having events observed in at least one individual; and
the boundaries of a CNV were defined by the longest event
among individuals. There were 401 regions where putative
CNVs from the non-smoothed segmentation intersected
putative regions from the smoothed segmentation. In regions
where multiple putative CNVs from the non-smoothed seg-http://genomebiology.com/2009/10/11/R125 Genome Biology 2009,     Volume 10, Issue 11, Article R125       Matsuzaki et al. R125.16
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mentation corresponded to one putative region from the
smoothed segmentation, the non-smoothed CNVs were cho-
sen. In regions of one-to-one correspondence, the generally
longer putative CNVs from the smoothed segmentation were
chosen.
Segmentation: CNV typing
The sample-level event calling thresholds used in the segmen-
tation analysis of the CNV-typing array data were determined
by comparing against reference event calls taken primarily
from the McCarroll et al. [14] study and, to a lesser extent,
from the PCR validation. The McCarroll et al. [14] study
reported integer copy number calls at 1,301 CNVs in 270 indi-
viduals from the HapMap Project, including the 90 Yoruba.
Of these 1,301 CNVs, 1,153 regions were represented on the
CNV-typing array by at least one probe partition correspond-
ing to regions overlapping at least two records in the DGV
(November 2008). These 1,153 CNVs were grouped into a
subset of 859 CNVs with at least one reported event in a
Yoruba, and a second subset of 294 regions that did not have
any Yoruba events reported in the McCarroll et al. [14] study.
These non-Yoruba event regions were further checked against
five other papers cited in the DGV [13,15,20,30,31], where
events were reported in at least one Yoruba. Of the subset of
294 CNVs without Yoruba events in the McCarroll et al. [14]
study, 234 regions had no reported Yoruba events in any of
the five other papers. After excluding no-calls from the
McCarroll et al. [14] study, there were a total of 20,847 dip-
loid calls at the 234 regions in 90 Yoruba (listed as REF-
NonPoly6papers in Additional data file 8). These diploid calls
were used as reference to assess call specificity, as reflected in
false-positive event observations. Initial comparisons of
CNV-typing data with the 859 CNVs having reported Yoruba
events in the McCarroll et al. [14] study, showed that a subset
of 127 regions had reported calls that agreed only when offset
by one integer. Comparisons with calls reported in the five
other papers with Yoruba events showed lower agreement in
this subset of 127. A cursory examination of HapMap geno-
types suggested higher congruence with offset calls at many of
the 127 regions, where, for example, one-copy-loss events
should correspond to consecutive SNP loci with homozygous
genotypes, but instead diploid copy number calls were
reported. After omitting these 127 regions, the remaining 732
CNVs from the McCarroll et al. [14] study had 7,752 reported
events that were used as reference to assess event sensitivity
(listed as REF-McCarroll-Sel in Additional data file 8). Events
from PCRs shown in Tables S3 and S5 in Additional data file
1, and in Additional data file 3 were also used as reference
(listed as pcr-GS in Additional data file 8).
To assess specificity and sensitivity of event detection in the
CNV-typing data, segmentation thresholds were titrated at
the 732 McCarroll reference CNVs, and at 6,578 putative
CNVs from the genome scan. Any false positives or false neg-
atives in the McCarroll reference event calls will artificially
lower the estimates of sensitivity or specificity, respectively,
of the CNV-typing array. Figure S6 in Additional data file 1
summarizes the results at seven threshold values that ranged
from 0.35 (-0.35) to 0.10 (-10), and shows the trade-off
between higher specificity and lower sensitivity. Event
thresholds of -0.175 and 0.175 for loss and gain calls, respec-
tively, were chosen; based on further titrations, second-level
thresholds of -0.70 and 0.45 were chosen for homozygous
deletions and multi-copy gain events, respectively. For each
individual Yoruba sample, sets of probes for each CNV were
analyzed separately by CBS, and segments with log2 ratios
above or below the thresholds were called as events. Probes in
the CNV-typing design were grouped into partitions corre-
sponding to known or putative CNVs, where a given CNV may
be represented by more than one partition (Figure S1B in
Additional data file 1). Although the CNVs vary in the number
and density (probes per base-pair) of corresponding probes,
the degree of discrimination of log2 ratios above or below the
event thresholds were comparable across a range of event
lengths and numbers of probes, with only slight loss of dis-
crimination at longer lengths and fewer probes (Figure S7 in
Additional data file 1). Microarray raw intensities and chip
library files are available at ArrayExpress [42] under acces-
sion number E-TABM-838. Reported CNVs are displayed at
the DGV [51].
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Additional data files
The following additional data are available with the online
version of this paper: Figures S1 to S7 and Tables S3, S5, S6
and S7 (Additional data file 1); a table listing confirmed and
putative CNVs (Additional data file 2); a table listing PCR val-
idation results at 44 regions along with gel images, which cor-
respond to 4% agarose (E-gel), gradient polyacrlyamide (PA
gel), and 1% agarose (1% gel) electrophoresis gels (Additional
data file 3); list of event calls and consensus reference in trios
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sizes of the expected amplicons (Additional data file 5); inte-
ger copy number events observed on the CNV-typing array in
90 Yoruba at 6,368 confirmed CNVs (Additional data file 6);
observed events on the CNV-typing array in the 90 Yoruba at
1,153 CNVs reported in the McCarroll et al. [14] study (listed
as chp-McCarroll2008) and at regions from the Levy et al.
[18] and Wheeler et al. [19] studies as summarized in Table 4
(listed as chp-LevyWheel, chp-LevyOnly, and chp-
WheelerOnly) (Additional data file 7); reported events from
six papers that included at least one Yoruba (Additional data
file 8).
Additional data file 1 Figures S1 to S7 and Tables S3, S5, S6 and S7 Figure S1 is a description of the chip designs. Figure S1A: the  sequential 49-mer probes against the genome were dispersed  across the three chip designs. Probes corresponding to extraneous  matches to the genome in the central 16 nucleotides were omitted  from the designs. Figure S1B: probes on the CNV-typing design  were organized into probe partitions corresponding to putative  CNVs from the genome scan (in red), reported CNVs from whole- genome sequencing studies (Levy et al. [18] and Wheeler et al. [19];  in blue), and CNV regions in the DGV (November 2008) overlap- ping in at least two database records (in green). The five example  partitions correspond to regions of varying length, and are repre- sented by up to 50 probes each; regions less than 500 bp have fewer  probes because the probe spacing is capped at 10 bp per probe. A  partition can map to more than one CNV; conversely, a CNV can be  represented by one or more partitions. Figure S2 shows regions  with reported CNVs in proximity. Two example regions of width  approximately 200 kb (Figure S2A) and approximately 20 kb (Fig- ure S2B) are displayed in Nexus chromosome views (BioDiscov- ery), along with DGV browser views [51]. The Nexus views show the  percentage of Yoruba samples with observed gains and losses in  green and red, respectively. DGV records that were paired with  putative CNVs are colored with blue stripes. In the first example  (Figure S2A), the DGV records with red stripes more closely match  the smaller CNVs. Figure S3 shows cell line artifacts. The initial  smoothed segmentation analysis, displayed in Nexus (BioDiscov- ery) drill-down views, showed disproportionately high gain events  across chromosome 12 in Yoruba sample NA19193 (Figure S3A)  and chromosome 9 in sample NA19208 (Figure S3B). The green  and red bars along the chromosome pictograms mark regions with  gains and losses, respectively. These observations are consistent  with previously reported lymphoblastoid cell-line artifacts, namely  mosaic duplications, in these samples [12,44]. Figure S4 shows  probe GC filtering and correction. Figure S4A: a handful of sam- ples, including NA18870, showed disproportionately high numbers  of events in the initial segmentation analysis when using all probes  and without GC correction. The plots show log ratios across the  range of probe GC content for a random sampling of 20,000 probes  in chromosome 20 from the b-chip experiment run on sample  NA18870. Before probe filtering and correction, there is a noticea- ble 'fishtail' of high log ratios corresponding to higher GC content,  which manifests in artificially high numbers of gain events. Simi- larly, in samples with high numbers of loss events, tails of low log  ratios were observed. Figure S4B: segmentation analysis results for  chromosome 20 from the b-chip experiment run on sample  NA18870. The average log ratios of the delineated segments are  plotted against their lengths (in log scale). Before the filtering and  correction, there is a noticeable bolus of segments with lengths  between approximately 500 kb and approximately 5 kb that have  average log ratios well above the threshold value of 0.25 for gains.  There are also longer segments up to approximately 500 kb that  have ratios above the 0.25 threshold. After filtering and correction,  however, the number of segments above or below the 0.25 and - 0.25 thresholds is much fewer, and the vast majority of segments  have average ratios hovering close to 0, indicative of non-events,  and lengths close to approximately 200 kb, which is in line with the  windows of 750 probes in the segmentation analysis. Figure S5 is a  receiver operator characteristic (ROC) analysis of chromosome X.  The ROC curves show the tradeoff between false positives and sen- sitivity [52], based on comparing chromosome X probes in female  and male samples. Log2 ratios were calculated for all 90 samples at  approximately 470,000 chromosome X probes in each chip design,  using median signals based only on female samples. Ratios close to  0 are indicative of two copies of chromosome X (non-events), while  lower ratios, particularly in male samples, are indicative of one  copy (surrogate 'loss' events). Thresholds for the ratios were varied  from -3.0 to 3.0 in 0.01 increments, and at each increment the  cumulative fraction of probes below the thresholds were deter- mined separately for female and male samples. The ROC curves  show sensitivity as the fraction of probes in males below the thresh- old, and the false positives as the log of the fraction of probes in  females below the threshold. Consecutive probes were averaged to  generate the family of smoothed curves. The ROC curve for the b- chip design is shown in panel A, while panel B shows the result of  combining consecutive inter-digitated probes from the three chip  designs. At the segmentation threshold of -0.25 for loss events, the  b-chip had sensitivity of 0.83 and false positives of 0.08 without  smoothing (all in panel A), and sensitivity of 0.91 and false posi- tives of 0.008 when smoothing with eight probes (smooth 8 in  panel A). The sensitivity was 0.88 and false positives 0.05 when  smoothing over three probes combined from the three designs  (smooth 3 in panel B). Compared with just the b-chip alone, these  ROC measures for the combined probes suggested higher perform- ance at the same effective resolution. However, the segmentation  with the combined probes resulted in greater variation in the tallies  of events in individual samples, compared to probes from each  design separately. Because the ROC measures are based on aggre- gating the entire sample set, subtle variations that manifest at the  individual sample level may not be apparent. Figure S6 is a thresh- old titration curve. CBS event thresholds were titrated from 0.35  (most stringent) down to 0.10. Sensitivity (y-axis) represents the  proportion of empirically detected events on the CNV-typing array  at 1,153 McCarroll CNVs and 6,578 putative CNVs, compared to  reference events at the 732 McCarroll reference CNVs and valida- tion PCRs (listed as REF-McCarroll-Sel and pcr-GS in Additional  data file 8), respectively. Because of the possibility of false-positive  calls in the McCarroll et al. [14] study, and the small sampling size  of the PCRs, the sensitivity estimates are approximations useful for  comparing CBS thresholds, and not absolute measures. The x-axis,  1 - Specificity, represents the proportion of possibly false-positive  events called on the CNV-typing array at McCarroll CNVs com- pared to reported diploid calls at the 234 non-event CNVs from the  McCarroll et al. [14] study (listed as REF-NonPoly6papers in Addi- tional data file 8). Any instances of false-negative events missed in  the McCarroll et al. [14] study that were actually called in our sur- vey will artificially lower the specificity estimates. Figure S7 are  plots of event segment Log2 ratios. Log2 ratios of 97,953 event seg- ments at the 6,368 confirmed CNVs were grouped based on  rounded segment lengths (Figure S7A), or rounded numbers of  probes (log2) in the segments (Figure S7B), and summarized in  box-plots for either gain or loss events. Box-plots show medians  and interquartile ranges, with whiskers extending to maximum or  minimum values within 1.5 times the 75th or 25th percentiles,  respectively. The width of boxes is proportional to the number of  events. Table S3 shows breakpoint mapping. Table S3A: amplicon  bands corresponding to 19 loss events at 16 regions were excised  from gels and sequenced. Shown are the build 36 reference  sequences 50 nucleotides upstream and downstream of the  mapped breakpoints of the loss events. Differences from the refer- ence sequence in individual Yoruba samples are in lower case. The  actual lengths (len) based on the breakpoints are listed. At putative  CNV locus_ids 3262, 3689, and 5439, the non-event DNA in  Yoruba pairs also had actual events at the exact same breakpoints  as in the event DNAs. Table S3B: the 16 regions with successful  breakpoint sequences are listed along with the closest matching  records in the DGV (March 2009). Table S5 is a summary of quan- titative PCR results at 16 putative CNVs. DNAs were run in pairs  with one having an observed gain event, and the other with no  event on the genome-scan arrays. Cycle thresholds (Ct) were nor- malized against GAPDH PCRs, and compared in each DNA pair. In  all cases, the event DNA had a lower Ct value. The status of each  pair was marked based on differences in normalized Ct values: con- firm or maybe (ambiguous). The differences in the Ct values were  scaled, such that difference less than or equal to 0.6 are represented  by one '+' symbol, and differences greater than 0.6 are represented  by a proportionate number of two or more '+' symbols  (Scaled_Diff_Ct). At four of the CNVs, the difference in Ct values  was dramatic, indicative of homozygous losses in the non-event  DNAs, rather than gains in the event DNAs. Table S6 is a list of ref- erences cited in the DGV alongside the methods used in the studies.  For the pair-wise comparison shown in Figure 3, methods from the  cited references were classified into the six categories. The num- bers of overlapping confirmed CNVs from our work is also listed.  Table S7 is a comparison of Yoruba event calls among six studies.  Reported events were compared in all possible pairs of six recent  studies that included one or more Yoruba individuals. Just as in the  comparisons shown in Table 2, for each Yoruba in common, events  were matched based on the longest overlap, and agreement was  determined by comparing loss versus gain events, and not integer  copy numbers. The percentage of events that overlapped reflects  the relative degree of missed events in either of the studies in the  paired comparisons. Click here for file Additional data file 2 Confirmed and putative CNVs Each putative CNV identified in the genome scan was assigned a  unique identifier (locus_id). CNVs with locus_id numbers starting  at 100,000 were from the smoothed segmentation analysis. Chro- mosome locations are on genome build 36. Confirmed CNVs had at  least one Yoruba with an event on the CNV-typing array. For con- firmed CNVs that overlapped at least one DGV record (March  2009), the closest matching record (variation_id) is listed along  with its build 36 coordinates, length, cited reference, and discovery  method. Regions were flagged as 'Complex' if both a loss and gain  event were observed in the same individual. Click here for file Additional data file 3 PCR validation results at 44 regions along with gel images, which  correspond to 4% agarose (E-gel), gradient polyacrlyamide (PA  gel), and 1% agarose (1% gel) electrophoresis gels. Gel images correspond to 4% agarose (E-gel), gradient polyacrlya- mide (PA gel), and 1% agarose (1% gel) electrophoresis gels. DNAs  were run in pairs with one having an observed event (Event  DNA_ID), and the other without an observed event (non-event  DNA_ID). Confirmation calls (Call Lane 1 or 2) were made based  on amplicon length differences in each DNA pair, and marked the  status of each pair: confirm, maybe (ambiguous), no (no evidence  of event), or fail (PCR did not yield expected amplicons). At a sub- set of regions, amplicon bands were excised and sequenced (seq).  The lengths of the putative CNVs are also listed. Click here for file Additional data file 4 Event calls and consensus reference in trios (A) Event calls at confirmed CNVs are compared against consen- sus references from the Wang et al. [15] and McCarroll et al. [14]  studies. Calls in red are in disagreement with the reference, and  calls in blue are cases of possible false-positive calls not in the ref- erence. Missed gain and loss events are shown as blue and red  boxes, respectively. Consensus among the references and agree- ment with the references were determined by comparing loss ver- sus gain events, and not integer copy numbers. Trio_ids are  detailed in (D). (B) Calls reported in the McCarroll et al. [14] study  are compared against consensus reference from our survey and the  Wang et al. [15] study. (C) Calls reported in the Wang et al. [15]  study are compared against consensus reference from our survey  and the McCarroll et al. [14] study. (D) Yoruba trios were arbitrar- ily assigned trio_ids. The DNA_ids of the 90 Yoruba are listed with  the corresponding trio_ids. Click here for file Additional data file 5 Primer sequences, along with sizes of the expected amplicons Primer sequences, along with sizes of the expected amplicons. Click here for file Additional data file 6 Integer copy number events observed on the CNV-typing array in  90 Yoruba at 6,368 confirmed CNVs Log 2 ratios of the event segments are also listed, along with event  coordinates on genome build 36. Click here for file Additional data file 7 Observed events on the CNV-typing array in the 90 Yoruba at 1,153  CNVs and at regions summarized in Table 4 Observed events on the CNV-typing array in the 90 Yoruba at 1,153  CNVs reported in the McCarroll et al. [14] study (listed as chp- McCarroll2008) and at regions from the Levy et al. [18] and  Wheeler et al. [19] studies as summarized in Table 4 (listed as chp- LevyWheel, chp-LevyOnly, and chp-WheelerOnly). Click here for file Additional data file 8 Reported events from six papers that included at least one Yoruba When available, event calls were listed as integer copy numbers  from 0 to 4, reported copy numbers > 4 were listed as 4, and no- calls were listed as -1. In papers that reported only loss (deletion) or  gain, the calls were listed as 1 or 3, respectively. For papers with  genome positions in build 35, the liftOver utility at UCSC [53] was  used to map coordinates on build 36. Also listed are diploid calls in  Yoruba from the McCarroll et al. [14] study (listed as REF- NonPoly6papers), and event calls based on PCR (listed as pcr-GS). Click here for file
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